Some clinical trials are currently ongoing in GBM, testing CTLA-4 inhibitors along with other therapeutics such as VEGF inhibitors (bevacizumab), chemotherapy (TMZ), tumor treating fields and RT [216]. Here, VEGFA is linked to neoplasm.